AF
AGIO icon

Allworth Financial’s Agios Pharmaceuticals AGIO Stock Holding History

Allworth Financial’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.1K Buy
1,971
+1,903
+2,799% +$57.7K ﹤0.01% 2169
2026
Q1 		$2.3K Buy
68
+57
+518% +$1.62K ﹤0.01% 4307
2025
Q4 		$300 Sell
11
-6
-35% -$211 ﹤0.01% 4639
2025
Q3 		$683 Buy
17
+2
+13% +$75 ﹤0.01% 4358
2025
Q2 		$499 Buy
15
+4
+36% +$121 ﹤0.01% 4138
2025
Q1 		$322 Sell
11
-53
-83% -$1.76K ﹤0.01% 3783
2024
Q4 		$2.18K Hold
64
– – ﹤0.01% 3126
2024
Q3 		$2.84K Buy
64
+4
+7% +$182 ﹤0.01% 2811
2024
Q2 		$2.8K Hold
60
– – ﹤0.01% 2774
2024
Q1 		$1.75K Buy
+60
New +$1.61K ﹤0.01% 2857
2023
Q4 		– Sell
-5
Closed -$124 – 3454
2023
Q3 		$124 Sell
5
-15
-75% -$397 ﹤0.01% 3304
2023
Q2 		$567 Buy
+20
New +$498 ﹤0.01% 2868

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Allworth Financial's AGIO Position: Q2 2026 in Review

Allworth Financial increased its Agios Pharmaceuticals (AGIO) stake by 2,799% in Q2 2026, buying an estimated $57.7K and bringing the position to 1,971 shares worth $73.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2169.

Allworth Financial first reported a position in AGIO in Q2 2023 and has held it in 12 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Allworth Financial held 1,971 shares of Agios Pharmaceuticals worth $73.1K as of Q2 2026.
  • Allworth Financial bought 1,903 Agios Pharmaceuticals shares in Q2 2026, an estimated $57.7K.
  • Agios Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2169 holding.
  • Allworth Financial first reported a position in Agios Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.